EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Effect of ivermectin on Toxocara canis larvae in vitro and in vivo at different migratory stages

Iman Fathy Abou-El-Naga iD, Suzanne M F El-Nassery iD, Mona M El-Temsahy iD

Biomédica · 02.03.2026 · 46 (1) · 128-140

DOI: 10.7705/biomedica.7828 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomédica, online erschienen am 02.03.2026. Verfasst von Iman Fathy Abou-El-Naga und 2 weiteren Autor:innen. Beteiligte Einrichtung: Medical Parasitology Department, Faculty of Medicine, Alexandria University, Alexandria Governorate, Egypt. Hauptthemen laut MEDLINE: Ivermectin, Toxocara canis, Toxocariasis, Antiparasitic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Ivermectin has shown potent activity against various nematodes.

Objective

Evaluation of the efficacy of ivermectin against Toxocara canis larvae.Materials and methods. In vitro assessment was conducted using larval migration inhibition test and scanning electron microscopy (SEM). In vivo, ivermectin was administered orally to mice at a single 0.2 mg/kg dose at 2 (group I), 7 (group II), or 15 days (group III) post-infection. Efficacy was evaluated through brain larval counts and histopathological examination of liver and brain.

Results

In vitro, ivermectin at concentrations of 10 μg/ml and 100 μg/ml inhibited larval migration by 8.5% and 87%, respectively. SEM showed cuticular damage after 24 and 48 hours with 100 μg/ml ivermectin. In vivo, brain larval counts significantly decreased in groups I and II (22.67 ± 5.41 and 37.17 ± 5.98), with no significant reduction in group III (130.5 ± 9.01). Histopathology of the liver at four weeks post-infection in groups I and II revealed numerous granulomas with degenerated larvae. The brain showed a marked reduction in larval presence and inflammation in groups I and II, while group III findings were similar to those of the control group.

Conclusion

Ivermectin is effective against T. canis larvae during early migratory stages but shows limited efficacy against late-stage larvae.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

IvermectinToxocara canisToxocariasisAntiparasitic AgentsAnimalsLarvaMiceLiverBrainMicroscopy, Electron, ScanningFemale

Stichwörter der Autor:innen

Toxocara canisivermectinmicroscopy, electronscanningtoxocariasis/pathology

Substanzen

IvermectinAntiparasitic Agents

Autor:innen und Institutionen

  • Medical Parasitology Department, Faculty of Medicine, Alexandria University, Alexandria Governorate, Egypt.

ORCID-Profile: Iman Fathy Abou-El-Naga, Suzanne M F El-Nassery, Mona M El-Temsahy

Zitieren

APA

Abou-El-Naga, I. F., El-Nassery, S. M. F., & El-Temsahy, M. M. (2026). Effect of ivermectin on Toxocara canis larvae in vitro and in vivo at different migratory stages. Biomédica, 46(1), 128-140. https://doi.org/10.7705/biomedica.7828

Vancouver

Abou-El-Naga IF, El-Nassery SMF, El-Temsahy MM. Effect of ivermectin on Toxocara canis larvae in vitro and in vivo at different migratory stages. Biomédica. 2026;46(1):128-140. doi:10.7705/biomedica.7828

BibTeX
@article{AbouElNaga2026,
  author = {Abou-El-Naga, Iman Fathy and El-Nassery, Suzanne M F and El-Temsahy, Mona M},
  title = {Effect of ivermectin on Toxocara canis larvae in vitro and in vivo at different migratory stages},
  journal = {Biomédica},
  year = {2026},
  volume = {46},
  number = {1},
  pages = {128--140},
  doi = {10.7705/biomedica.7828}
}
Kostenlos starten →